Ringpu Bio-Technology approves equity transfer at shareholder meeting

Tianjin Ringpu Bio-Technology (SZSE:300119) successfully held its third extraordinary general meeting of shareholders on June 30, 2025, with 203 shareholders and proxies representing 40.4567% of the company's total shares. The meeting, convened and conducted in accordance with relevant laws and the company's articles of association, saw the approval of a key resolution regarding the transfer of equity in a subsidiary and a related investment project. Specifically, 99.8092% of voting shareholders supported the resolution. The Beijing Tongshang Law Firm provided a legal opinion, confirming the legitimacy of the meeting's procedures and the validity of the resolutions passed.